US 2023/0146096 A1 · USE OF VIDOFLUDIMUS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS

Use of vidofludimus for the treatment of coronavirus infections

AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Universite D'Aix-Marseille, Assistance Publique - Hopitaux De Marseille, Centre National de la Recherche Scientifique (CNRS), Ecole Normale Superieure De Lyon, Institut De Recherche Pour Le Developpement (Ird), Universite Claude Bernard Lyon 1

InventorsPierre-Olivier VIDALAIN, Vincent LOTTEAU, Patrice ANDRE, Franck TOURET, Xavier Nicolas DE LAMBALLERIE, Antoine NOUGAIREDE

Life of this patent

Estimating the term…

Abstract

Coronaviridae is a family of enveloped, positive-sense, single-stranded RNA viruses. The emergence of a new betacoronavirus SARS-CoV-2 has led to a major health-related crisis associated with a significant mortality in intensive care units, due to the pulmonary complications of COVID-19. The inventors showed that Vidofludimus is suitable for inhibiting replication of coronavirus and thus would be suitable for the treatment of infections mediated by said type of virus.

Claims4

Dependent claims

A method of treating a coronavirus infection in a subject in need thereof comprising administrating to the subject a therapeutically effective amount of Vidofludimus.

Dependencies are inferred from the claim text.

Facts

Application

17/995,809Filed 9 Apr 2021

Priority

EP 20315150.110 Apr 2020

Published

11 May 2023

Term ends

Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 31/192
Carboxylic acids, e.g. valproic acid: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
A61K 31/196
Having an amino group: the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
A61K 31/53
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with three nitrogens as the only ring hetero…
A61P 31/14
Antivirals: for RNA viruses